Successful and rapid reduction of viral load one week prior to C-section with ART including enfuvirtide

J. Thoden, S. Usadel, H. Löffler, M. Kunze, D. Wagner & W.V. Kern
Introduction: Prevention of MTCT is mainly based on a reduction of maternal viral load (VL) <1000 c/ml prior to delivery. Late presenters are at increased risk of transmitting HIV to the newborn. According to the German-Austrian recommendations antiretroviral therapy (ART) during pregnancy[for full text, please go to the a.m. URL]